Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHEK2 | O96017 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
| ▸ | MAPT | P10636 | 2/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | BRCA1 | P38398 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | ATM | Q13315 | 1/20 | 0.30 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.30 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22192705 | 0.97 | TSHR (0.32) | ALDH1A1TSHRMAPTHPGDMEN1 | |
| SCHEMBL22192251 | 0.93 | MAPT (0.35) | ALDH1A1TSHRMAPTHPGDMEN1 | |
| SCHEMBL22192325 | 0.93 | MAPT (0.35) | ALDH1A1TSHRMAPTHPGDMEN1 | |
| SCHEMBL22192711 | 0.93 | TSHR (0.32) | ALDH1A1TSHRMAPTMEN1POLB | |
| SCHEMBL22192406 | 0.93 | MAPT (0.33) | ALDH1A1TSHRMAPTHPGDMEN1 | |
| SCHEMBL22192273 | 0.93 | MAPT (0.33) | ALDH1A1TSHRMAPTHPGDMEN1 | |
| SCHEMBL22192472 | 0.93 | MAPT (0.34) | ALDH1A1TSHRMAPTHPGDMEN1 | |
| SCHEMBL21365546 | 0.92 | ALDH1A1 (0.35) | CHEK2ALDH1A1TSHRMAPTHPGD | |
| SCHEMBL22192316 | 0.92 | — | — | |
| SCHEMBL22192701 | 0.92 | TSHR (0.32) | ALDH1A1TSHRMAPTHPGDMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10703762-B2 | Compound, material for organic electroluminescence device, organic electroluminescence device and electronic apparatus | IDEMITSU KOSAN CO., LTD. (JP) | 2020-07-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10703762-B2 | Compound, material for organic electroluminescence device, organic electroluminescence device and electronic apparatus | PIEZO1, OR10J3, EPCAM | CHEK2 3815/4885ALDH1A1 145/4885TSHR 4280/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.